BCP
AMPE

Blackhawk Capital Partners’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Blackhawk Capital Partners’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-52
Closed -$7K – 99
2022
Q1 		$7K Hold
52
– – ﹤0.01% 83
2021
Q4 		$9K Hold
52
– – 0.01% 92
2021
Q3 		$26K Hold
52
– – 0.02% 93
2021
Q2 		$26K Buy
+52
New +$27.9K 0.02% 96
2021
Q1 		– Sell
-52
Closed -$15K – 105
2020
Q4 		$15K Hold
52
– – 0.01% 91
2020
Q3 		$10K Buy
+52
New +$12.9K 0.01% 86

Other funds holding AMPE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Blackhawk Capital Partners's AMPE Position: Q2 2022 in Review

Blackhawk Capital Partners sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2022, closing a stake of 52 shares — an estimated $7K sold.

Blackhawk Capital Partners first reported a position in AMPE in Q3 2020 and held it in 6 quarters. The position peaked at $26K in Q3 2021. 111 funds tracked by Wall St. Rank hold AMPE as of Q2 2022.

  • Blackhawk Capital Partners reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2022 after selling out during the quarter.
  • Blackhawk Capital Partners sold 52 Ampio Pharmaceuticals Inc. shares in Q2 2022, an estimated $7K.
  • Blackhawk Capital Partners first reported a position in Ampio Pharmaceuticals Inc. in Q3 2020 and held it in 6 quarters.
  • Blackhawk Capital Partners's Ampio Pharmaceuticals Inc. position peaked at $26K in Q3 2021.
  • 111 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2022.

Based on Blackhawk Capital Partners's 13F filing for Q2 2022, filed 8 Aug 2022.